Answers are grounded in this paper and cite their sources.
Background: Neuromyelitis Optica Spectrum Disorders (NMOSD) are a group of neuroinflammatory conditions that affect the nervous system. MLR and PLR are simple inflammatory biomarkers and are studied in many autoimmune and demyelinating diseases. In this study, we investigate the available evidence to determine whether MLR and PLR are higher in NMOSD patients than in healthy subjects. Methods: Systematic review and meta-analysis of studies measuring levels of PLR and/or MLR in both NMOSD patients and healthy controls were conducted. Mean difference (MD) and 95% confidence interval (CI) were used to measure the difference in levels of MLR and PLR between patients and healthy subjects. Results: For MLR, the main meta-analysis yielded a pooled MD of 0.125 [-0.114; 0.363]. I2 was 83.8%. Subgroup meta-analysis of age- and sex-matched studies, demonstrated a pooled MD of 0.066 [0.012; 0.12]. For PLR, meta-analysis revealed a pooled MD of 23.99 [6.03; 41.96]. I2 was 82.3%. Subgroup analysis for age- and sex-matched studies for PLR, showed a pooled MD of 14 [-19.68; 47.68]. Conclusion: The main analysis suggests that MLR is not higher in NMOSD patients than in healthy controls. However, subgroup analysis of age- and sex-matched studies and leave-one-out analysis excluding the outlier study showed a statistically significant MLR increase in patients. PLR was found to exhibit a modest increase in NMOSD patients compared with healthy controls. Nonetheless, subgroup analysis of age- and sex-matched studies showed a statistically non-significant increase. Results should be interpreted cautiously. The available evidence is inconsistent and further research is needed.
No takes yet. Share an insight, caveat, or question.
Shouman et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: